Sabra Q2 FY26 net loss widens to $0.10 a share; revenue rises 24.7% to $235.87 million
Reuters2026/08/03 20:07- Sabra Health Care REIT posted a net loss of $0.10 per diluted share in Q2 2026, swinging from net income of $0.27 a year earlier.
- FFO per diluted share turned to a loss of $0.02 from a profit of $0.44, while normalized FFO rose to $0.38 from $0.37.
- Revenue increased 24.69% to $235.87 million, driven by resident fees and services rising to $128.8 million from $78.99 million.
- Same-property managed senior housing cash NOI increased 13.7% year over year, while skilled nursing/transitional care rent coverage was 2.49x.
- Management highlighted about $600 million of year-to-date investments; Sabra reiterated full-year 2026 guidance.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Xenia Hôtellerie Solution announces extraordinary shareholder meeting
Community Reacts As Pundit Claims XRP Will Be Priced At $2,953 By Q2 2027
Colgate-Palmolive (CL.US) plans to sell part of its personal care brands, with a total transaction amount possibly exceeding 1.1 billions USD.
According to sources familiar with the matter, Colgate is exploring the sale of some of its mass-market personal care brands. The company currently plans to divest only a few brands within its personal care business, and the combined sale price may exceed 1 billion dollars.
Crypto prices
More
